EUVIMEDEUVIMED entdecken
Crossref

Glycyrrhizic acid inhibits DNA damage repair and enhances cisplatin‐induced apoptosis of melanoma cells

Fang Bian, Fan-Hong Niu, Ping-Yuan Qu, Fang Gong, Jian-Zhou Yan

Chemical Biology & Drug Design · 2024

DOI: 10.1111/cbdd.14536 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2024. Verfasst von Fang Bian und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Gansu Provincial Cancer Hospital, Lanzhou, Gansu, China. Hauptthemen laut MEDLINE: Cisplatin, Glycyrrhizic Acid, Apoptosis, Melanoma. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This research was designed to prospect the mechanism and impact of glycyrrhizic acid (GA) on DNA damage repair and cisplatin (CP)‐induced apoptosis of melanoma cells. First, human melanoma cell SK‐MEL‐28 was stimulated using GA for 24, 48, and 72 h. Then, the optimal treatment time and dosage were selected. After that, cell counting kit‐8 (CCK‐8) was employed for testing the cell viability, flow cytometry for the apoptosis, comet assay for the DNA damage of cells, and western blot for the cleaved‐Caspase3, Caspase3, Bcl‐2, and γH2AX protein expression levels. The experimental outcomes exhibited that as the GA concentration climbed up, the SK‐MEL‐28 cell viability dropped largely, while the apoptosis level raised significantly, especially at the concentration of 100 μm. In addition, compared with GA or CPtreatment only, CP combined with GA notably suppressed the viability of melanoma cells and promoted cell apoptosis at the cytological level. At the protein level, the combined treatment notably downregulated the Bcl‐2 and Caspase3 expression levels, while significantly upregulated the cleaved‐Caspase3 and γH2AX expression levels. Besides, CP + GA treatment promoted DNA damage at the DNA molecular level. Collectively, both GA and CP can inhibit DNA damage repair and enhance the apoptosis of SK‐MEL‐28 cells, and the synergistic treatment of both exhibits better efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinGlycyrrhizic AcidApoptosisMelanomaDNA DamageDNA RepairHumansCell Line, TumorCell SurvivalAntineoplastic AgentsCaspase 3Drug SynergismProto-Oncogene Proteins c-bcl-2

Stichwörter der Autor:innen

DNA damage repairapoptosiscisplatinglycyrrhizic acidmelanoma

Substanzen

CisplatinGlycyrrhizic AcidAntineoplastic AgentsCaspase 3Proto-Oncogene Proteins c-bcl-2

Autor:innen und Institutionen

  • Department of Dermatology, Gansu Provincial Cancer Hospital, Lanzhou, Gansu, China.
  • Department 1 of General Surgery, The Second People's Hospital of Lanzhou City, Lanzhou, Gansu, China.

Zitieren

APA

Bian, F., Niu, F. H., Qu, P. Y., Gong, F., & Yan, J. Z. (2024). Glycyrrhizic acid inhibits DNA damage repair and enhances cisplatin‐induced apoptosis of melanoma cells. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.14536

Vancouver

Bian F, Niu FH, Qu PY, Gong F, Yan JZ. Glycyrrhizic acid inhibits DNA damage repair and enhances cisplatin‐induced apoptosis of melanoma cells. Chemical Biology & Drug Design. 2024. doi:10.1111/cbdd.14536

BibTeX
@article{Bian2024,
  author = {Bian, Fang and Niu, Fan-Hong and Qu, Ping-Yuan and Gong, Fang and Yan, Jian-Zhou},
  title = {Glycyrrhizic acid inhibits DNA damage repair and enhances cisplatin‐induced apoptosis of melanoma cells},
  journal = {Chemical Biology & Drug Design},
  year = {2024},
  doi = {10.1111/cbdd.14536}
}
Kostenlos starten →